Article
Race-Associated EGFR and KRAS Mutation Profiles in Lung Adenocarcinoma.
Genes - 16 Aug 2026
Dios Lovyanne Vergel de, Wu Catherine, Shaham Salique H, Tripathi Manish K
Abstract excerpt
BACKGROUND: Lung adenocarcinoma (LUAD) is the most prevalent histologic subtype of non-small cell lung cancer (NSCLC) and exhibits considerable molecular heterogeneity. Among the most clinically significant driver alterations are mutations in EGFR and KRAS, both of which influence treatment selection and oncologic outcomes. The prevalence of these mutations varies by race, yet racial minority populations remain...
Topics
Join the communities discussing this publication.